Wuhan Keqian Biology Co. Ltd.SSE: 688526

(688526)"Wuhan Keqian Biology Co., Ltd."Report for Q3 2026

· Issued by Wuhan Keqian Biology Co. Ltd. via Shanghai Stock Exchange

Filed with SSE · Stock code 688526 · · 14 pages · Chinese

Summary by 6ix AI

The report indicates significant declines in revenue and profit compared to the same period last year, attributed to market conditions affecting sales. The company also highlights its ongoing research and development efforts, including the acquisition of new veterinary drug registrations.

Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries

Wuhan Keqian Biology Co. Ltd. on 6ix

Earlier from Wuhan Keqian Biology

Later from Wuhan Keqian Biology

All Wuhan Keqian Biology news releases